BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Reinglas J, Gonczi L, Kurt Z, Bessissow T, Lakatos PL. Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases. World J Gastroenterol 2018; 24(32): 3567-3582 [PMID: 30166855 DOI: 10.3748/wjg.v24.i32.3567]
URL: https://www.wjgnet.com/1007-9327/full/v24/i32/3567.htm
Number Citing Articles
1
Tushar Shukla, Bruce E. Sands. Novel Non-biologic Targets for Inflammatory Bowel DiseaseCurrent Gastroenterology Reports 2019; 21(5) doi: 10.1007/s11894-019-0689-2
2
De-Gao He, Xi-Jie Chen, Juan-Ni Huang, Jun-Guo Chen, Min-Yi Lv, Tian-Ze Huang, Ping Lan, Xiao-Sheng He. Increased risk of colorectal neoplasia in inflammatory bowel disease patients with post-inflammatory polyps: A systematic review and meta-analysisWorld Journal of Gastrointestinal Oncology 2022; 14(1): 348-361 doi: 10.4251/wjgo.v14.i1.348
3
Nicole L. Mancini, Luke Goudie, Warren Xu, Rasha Sabouny, Sruthi Rajeev, Arthur Wang, Nicolas Esquerre, Ala Al Rajabi, Timothy S. Jayme, Erik van Tilburg Bernandes, Yasmin Nasser, José G.P. Ferraz, Timothy Shutt, Jane Shearer, Derek M. McKay. Perturbed Mitochondrial Dynamics Is a Novel Feature of Colitis That Can Be Targeted to Lessen DiseaseCellular and Molecular Gastroenterology and Hepatology 2020; 10(2): 287 doi: 10.1016/j.jcmgh.2020.04.004
4
Cindy CY Law, Conor Bell, Deborah Koh, Yueyang Bao, Vipul Jairath, Neeraj Narula. Risk of postoperative infectious complications from medical therapies in inflammatory bowel diseaseCochrane Database of Systematic Reviews 2020; 2021(12) doi: 10.1002/14651858.CD013256.pub2
5
Wenjuan Liu, Zirong Dong, Kaiheng Liu, Yi Lu, Wei Wu, Jianping Qi, Zhongjian Chen. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel diseaseInternational Journal of Pharmaceutics 2021; 600: 120461 doi: 10.1016/j.ijpharm.2021.120461
6
Sara Salvador-Martín, Beatriz López-Cauce, Olga Nuñez, Emilio J. Laserna-Mendieta, María I. García, Elena Lobato, Judith Abarca-Zabalía, María Sanjurjo-Saez, Alfredo J. Lucendo, Ignacio Marín-Jiménez, Luis A. Menchén, Luis A. López-Fernández. Genetic predictors of long-term response and trough levels of infliximab in crohn’s diseasePharmacological Research 2019; 149: 104478 doi: 10.1016/j.phrs.2019.104478
7
Balaji Venkataraman, Shreesh Ojha, Prasanna D. Belur, Bhoomendra Bhongade, Vishnu Raj, Peter D. Collin, Thomas E. Adrian, Sandeep B. Subramanya. Phytochemical drug candidates for the modulation of peroxisome proliferator‐activated receptor γ in inflammatory bowel diseasesPhytotherapy Research 2020; 34(7): 1530 doi: 10.1002/ptr.6625
8
Stuart Bloom, Tariq Iqbal, Chuka Nwokolo, Vipul Jairath, Jesse Hall, Bruce Dzyngel, Peter Gardzinski. 713 A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of a Targeted Release Oral Cyclosporine Formulation in the Treatment of Mild to Moderate Ulcerative Colitis: Influence of Immunosuppressants at BaselineAmerican Journal of Gastroenterology 2019; 114(1): S419 doi: 10.14309/01.ajg.0000592388.53875.b2
9
Cindy CY Law, Deborah Koh, Yueyang Bao, Vipul Jairath, Neeraj Narula. Risk of postoperative infectious complications from medical therapies in inflammatory bowel diseaseCochrane Database of Systematic Reviews 2019;  doi: 10.1002/14651858.CD013256
10
Yan Xu, Aditi Sharma, Yang Chen, Honghui Zhou. What We Can Learn from Current Inflammatory Bowel Disease (IBD) Biological Therapy—Dose Regimen and OthersCurrent Pharmacology Reports 2019; 5(3): 115 doi: 10.1007/s40495-019-00180-x
11
Yan Xu, Chuanpu Hu, Yang Chen, Xin Miao, Omoniyi J. Adedokun, Zhenhua Xu, Amarnath Sharma, Honghui Zhou. Population Pharmacokinetics and Exposure‐Response Modeling Analyses of Ustekinumab in Adults With Moderately to Severely Active Ulcerative ColitisThe Journal of Clinical Pharmacology 2020; 60(7): 889 doi: 10.1002/jcph.1582
12
Padhmanand Sudhakar, Dahham Alsoud, Judith Wellens, Sare Verstockt, Kaline Arnauts, Bram Verstockt, Severine Vermeire. Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for AllJournal of Crohn's and Colitis 2022;  doi: 10.1093/ecco-jcc/jjac027
13
Michel Adamina, Stefanos Bonovas, Tim Raine, Antonino Spinelli, Janindra Warusavitarne, Alessandro Armuzzi, Oliver Bachmann, Palle Bager, Livia Biancone, Bernd Bokemeyer, Peter Bossuyt, Johan Burisch, Paul Collins, Glen Doherty, Alaa El-Hussuna, Pierre Ellul, Gionata Fiorino, Cornelia Frei-Lanter, Federica Furfaro, Christian Gingert, Paolo Gionchetti, Javier P Gisbert, Fernando Gomollon, Marien González Lorenzo, Hannah Gordon, Tibor Hlavaty, Pascal Juillerat, Konstantinos Katsanos, Uri Kopylov, Eduards Krustins, Torsten Kucharzik, Theodore Lytras, Christian Maaser, Fernando Magro, John Kenneth Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, Joao Sabino, Edoardo Savarino, Laurents Stassen, Joana Torres, Mathieu Uzzan, Stephan Vavricka, Bram Verstockt, Oded Zmora. ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical TreatmentJournal of Crohn's and Colitis 2020; 14(2): 155 doi: 10.1093/ecco-jcc/jjz187
14
Sophie Restellini, Waqqas Afif. Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel DiseaseJournal of Clinical Medicine 2021; 10(6): 1242 doi: 10.3390/jcm10061242
15
Bob Geng, Timothy J. Craig. Small molecule drugs for atopic dermatitis, rheumatoid arthritis, and hereditary angioedemaAnnals of Allergy, Asthma & Immunology 2022; 128(3): 263 doi: 10.1016/j.anai.2021.10.015
16
Irene Marafini, Silvia Sedda, Vincenzo Dinallo, Giovanni Monteleone. Inflammatory cytokines: from discoveries to therapies in IBDExpert Opinion on Biological Therapy 2019; 19(11): 1207 doi: 10.1080/14712598.2019.1652267
17
Peter Kienle. Impact of Modern Drug Therapy on Surgery: Crohn's DiseaseVisceral Medicine 2018; 34(6): 422 doi: 10.1159/000495127
18
Boris Gole, Uroš Potočnik. Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn’s Disease—A Systematic Review and Gene Ontology AnalysisCells 2019; 8(6): 515 doi: 10.3390/cells8060515
19
Ciro Romano, Sergio Esposito, Roberta Ferrara, Giovanna Cuomo. Choosing the most appropriate biologic therapy for Crohn’s disease according to concomitant extra-intestinal manifestations, comorbidities, or physiologic conditionsExpert Opinion on Biological Therapy 2020; 20(1): 49 doi: 10.1080/14712598.2020.1689953
20
Elena Milanesi, Maria Dobre, Teodora E. Manuc, Gabriel Becheanu, Cristian G. Tieranu, Elena M. Ionescu, Mircea Manuc. Mucosal gene expression changes induced by anti‐TNF treatment in inflammatory bowel disease patientsDrug Development Research 2019; 80(6): 831 doi: 10.1002/ddr.21566
21
Maria Chiara Ditto, Simone Parisi, Gianpiero Landolfi, Richard Borrelli, Cristina Realmuto, Annacarla Finucci, Gian Paolo Caviglia, Davide Giuseppe Ribaldone, Marco Astegiano, Anna Zanetti, Greta Carrara, Carlo Alberto Scirè, Marco Antivalle, Piercarlo Sarzi-Puttini, Enrico Fusaro. Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritisRMD Open 2021; 7(3): e001755 doi: 10.1136/rmdopen-2021-001755
22
Jörg D. Schulzke, Michael Fromm. Ion Transport Across Epithelial Tissues and DiseasePhysiology in Health and Disease 2020; : 77 doi: 10.1007/978-3-030-55310-4_3
23
Michel Adamina, Gionata Fiorino. At the Crossroads of Caution and Intervention: Anti-TNF Therapy Prior to Elective CD SurgeryJournal of Crohn's and Colitis 2021; 15(10): 1778 doi: 10.1093/ecco-jcc/jjab092
24
Cecilia Dell’Avalle, Ferdinando D’Amico, Roberto Gabbiadini, Arianna Dal Buono, Nicola Pugliese, Alessandra Zilli, Federica Furfaro, Gionata Fiorino, Mariangela Allocca, Laurent Peyrin-Biroulet, Silvio Danese. JAK inhibitors in crohn’s disease: ready to go?Expert Opinion on Investigational Drugs 2022; 31(2): 145 doi: 10.1080/13543784.2022.2032639
25
Cynthia Morvillo, Katherine Vinci, Lauren Hedenschoug, Leah Mancini, Carrie Mize, Kayce Tugg, Steven Stein. Risks and Safety of Advanced Therapies and Biologics in Inflammatory Bowel DiseaseGastroenterology Nursing 2020; 43(4): E159 doi: 10.1097/SGA.0000000000000523
26
Pharmacokinetic Profiling and Simultaneous Determination of Thiopurine Immunosuppressants and Folic Acid by Chromatographic MethodsMolecules 2019; 24(19): 3469 doi: 10.3390/molecules24193469
27
Simon P. Borg-Bartolo, Ray Kiran Boyapati, Jack Satsangi, Rahul Kalla. Precision medicine in inflammatory bowel disease: concept, progress and challengesF1000Research 2020; 9: 54 doi: 10.12688/f1000research.20928.1
28
Young-Jae Hwang, Seung-Joo Nam, Wanjoo Chun, Song In Kim, Sung Chul Park, Chang Don Kang, Sung Joon Lee, Partha Mukhopadhyay. Anti-inflammatory effects of apocynin on dextran sulfate sodium-induced mouse colitis modelPLOS ONE 2019; 14(5): e0217642 doi: 10.1371/journal.pone.0217642